John LaMattina

John L.
LaMattina is the founder of Alivio Therapeutics, Inc. Dr. LaMattina currently serves as Independent Director at Ligand Pharmaceuticals, Inc. since 2011.
He is an Independent Non-Executive Director at PureTech Health LLC since 2009 and Senior Independent Non-Executive Director at PureTech Health Plc since 2009.
He holds trustee positions at Boston College, Worcester Polytechnic Institute, and the Terri Brodeur Breast Cancer Foundation.
Formerly, Dr. LaMattina was Chairman of Gelesis, Inc. from 2013 to 2019.
He was Director at Neurogen Corp.
from 2008 to 2010, Director at Thermo Electron Corp.
from 2002 to 2006, and Director at Human Genome Sciences, Inc. in 2012.
He served as Independent Director at Immunome, Inc. from 2017 to 2023 and Independent Director at Zafgen, Inc. from 2013 to 2020.
He was Director at Vedanta Biosciences, Inc. from 2012 to 2016, President at Pfizer (St. Louis) from 2001 to 2007, and Senior Vice President-Worldwide Development at Pfizer Inc. from 1999 to 2008.
He also held director roles at Thermo Fisher Scientific, Inc. from 2002 to 2006, and at Decision Options LLC and Ziarco Pharma Ltd. Education includes an undergraduate degree from Boston College in 1971 and a doctorate from the University of New Hampshire in 1975.